MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Stryker Stock

Stryker Corporation

SYKNYSERadar
US$294.66
+0.5% today

Company data

Sector
Healthcare
Industry
Medical - Devices
Country
United States
CEO
Kevin A. Lobo
Employees
56,000
Market cap
$113 B
IPO
17/03/1980

Stryker Corporation is a medical technology company within the healthcare sector, headquartered in Portage. Established in 1941, the corporation operates through two primary divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures, such as hips and knees, as well…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Stryker stock: price history

16/10/25-20.2 %16/10/26

1D

+0.5%

1W

+6.2%

1M

+3.5%

6M

-14.2%

YTD

-16.2%

1Y

-20.2%

2Y

-18.4%

5Y

+10.6%

10Y

+156.7%

Next earnings date

Next earnings date

29/10/2026 (in 12 days)

Volatility around earnings

~22% stronger price swings than usual

Pattern chart

Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 15/10/26. Not a buy or sell signal.Beta

What does this mean?

Volatility squeeze

Bullish

Price swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.

Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.

Ask the agents about Stryker

Analyst assessment of Stryker

PRICE TARGET LOW

US$310.00

CONSENSUS

US$365.89

MEDIAN

US$370.00

PRICE TARGET HIGH

US$420.00

1

STRONG BUY

36

BUY

15

HOLD

0

SELL

0

STRONG SELL

52

TOTAL · Buy

As of: 12/10/2026

ANALYST FIRMRATINGACTIONDATE
BTIGBuymaintain12/10/2026
Truist SecuritiesHoldmaintain07/10/2026
StifelBuymaintain30/09/2026
TD CowenHoldmaintain22/09/2026
Canaccord GenuityBuymaintain18/09/2026
CitigroupBuymaintain10/09/2026
Wells FargoOverweightmaintain09/09/2026
Wolfe ResearchOutperform → Peer Performdowngrade13/08/2026

Stryker stock metrics

P/E

30.28

P/B

4.71

EV/EBITDA

18.62

RETURN ON EQUITY

5.3%

NET MARGIN

19.4%

DEBT/EQUITY

0.62

DIVIDEND YIELD

1.2%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

90.8%

FLOAT SHARES

348,134,732

AVG. DAILY VOLUME (30D)

2,957,521

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

Wells Preston Wendell

OfficerJ109–Spontaneous28/09/2026

Wells Preston Wendell

OfficerJ1,777–Spontaneous24/09/2026

Wells Preston Wendell

OfficerJ962–Spontaneous24/09/2026

BRAINERD MARY K

DirectorPurchase3185.65Spontaneous02/09/2026

BRAINERD MARY K

DirectorPurchase36193.21Spontaneous02/09/2026
Page 1 / 13

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.5%

Forums (Reddit)

08/0917/0916/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
FENIMORE ASSET MANAGEMENT INC550,558+3,21830/09/2026
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/367,335+193,42030/09/2026
Perpetual Ltd338,569+336,62330/09/2026
DAVENPORT & Co LLC285,110-1,13330/09/2026
CONFLUENCE INVESTMENT MANAGEMENT LLC196,130-15,87030/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
30/09/202630/10/2026US$0.881.3 %
30/06/202631/07/2026US$0.881.1 %
31/03/202630/04/2026US$0.881 %
31/12/202530/01/2026US$0.881 %
30/09/202531/10/2025US$0.840.9 %
Page 1 / 8

Stock splits

DATERATIO
17/05/20042:1
15/05/20002:1
11/06/19962:1
14/06/19912:1
20/06/19893:2
Page 1 / 2

Comparable stocks

Frequently asked questions about Stryker stock

What does Stryker do?

Stryker Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.

The CEO is Kevin A. Lobo, the company employs around 56,000 people.

The IPO was on 17/03/1980; the stock trades on NYSE under the ticker SYK.

What do analysts say about Stryker stock?

52 analysts rate the stock, the consensus is Buy (as of 12/10/2026).

The average price target is US$365.89, ranging from US$310.00 to US$420.00, with a median of US$370.00.

This is an external assessment, not a statement by Market Jury.

When does Stryker report next?

The next earnings date is 29/10/2026.

Around past earnings, price swings were roughly 22% stronger than usual.

Does Stryker pay a dividend?

Yes. The last dividend was US$0.88 per share, ex-date 30/09/2026, paid on 30/10/2026.

The dividend yield is 1.2% (as of 30/06/2026).

Which stocks are comparable to Stryker?

Comparable stocks include Abbott Laboratories, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Align Technology and Bio-Rad Laboratories.

How can I get Stryker stock analyzed?

Clicking "Analyze stock" lets five strategies assess Stryker against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.